Toxicological assays in the evaluation of safety assessment of fibrinolytic enzymes
Marllyn Marques da Silva Yanara Alessandra Santana Moura Arthur Hipólito Pereira Leite Kerolayne Lira Da Silva Souza Romero Marcos Pedrosa Brandão Costa Thiago Pajeú Nascimento Ana Lúcia Figueiredo Porto Raquel Pedrosa Bezerra a Laboratório de Avanços em Biotecnologia de Proteínas e Tecnologia de Bioativos,Departamento de Morfologia e Fisiologia Animal,Universidade Federal Rural de Pernambuco,Recife,Pernambuco,Brasilb Departamento de Bioquímica,Centro Universitário de Patos – UNIFIP,Patos,Paraíba,Brasilc Instituto Ciências Biológicas,Universidade de Pernambuco,Recife,Pernambuco,Brasild Campus Professora Cinobelina Elvas,Universidade Federal do Piauí,Bom Jesus,Piauí,Brasil
DOI: https://doi.org/10.1080/01480545.2024.2367561
2024-08-20
Drug and Chemical Toxicology
Abstract:Cardiovascular diseases (CVDs) cause 30% of deaths each year, and in 2030, around 23.6 million people will die due to CVDs. The major challenge is to obtain molecules with minimal adverse reactions that can prevent and dissolve blood clots. In this context, fibrinolytic enzymes from diverse microorganism sources have been extensively investigated due to their potential to act directly and specifically on the fibrin clot, preventing side effects and performing potential thrombolytic effects. However, most researches focus on the purification and characterization of proteases, with little emphasis on the mechanism of action and pharmacological characteristics, including toxicity assays which are essential to assess safety and side effects. Therefore, this work aims to emphasize the importance of evaluations indicating the toxicological profile of fibrinolytic proteases through in vitro and in vivo tests. Both types of assays contribute as preclinical stage in drug development and are crucial for clinical applications. This scarcity creates arbitrary barriers to further studies. This work should further encourage the development of studies to ensure the safety and effectivity of fibrinolytic proteases.
pharmacology & pharmacy,toxicology,chemistry, multidisciplinary